Shopping Cart
- Remove All
- Your shopping cart is currently empty
Pomalidomide-PEG3-C2-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based cereblon ligand and 3-unit PEG linker used in PROTAC technology.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
100 mg | Inquiry | Backorder | |
500 mg | Inquiry | Backorder |
Description | Pomalidomide-PEG3-C2-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based cereblon ligand and 3-unit PEG linker used in PROTAC technology. |
Alias | Pomalidomide-PEG3-C2-NH2 (TFA) (2093416-31-8 free base), E3 ligase Ligand-Linker Conjugates 30 (TFA), Cereblon Ligand-Linker Conjugates 5 (TFA) |
Molecular Weight | 562.49 |
Formula | C23H29F3N4O9 |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||||||||||||
Solubility Information | H2O: 16.67 mg/mL (29.64 mM), Sonication is recommended. DMSO: 100 mg/mL (177.78 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||||||||||||
H2O/DMSO
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.